The comparison assessment of effectiveness of low-dose aspirin in women with gestational endotheliopathy for prevention of preeclampsia depending on beginning of treatment

dc.contributor.author	Konkov, D.	en
dc.date.accessioned	2017-10-18T14:40:42Z
dc.date.available	2017-10-18T14:40:42Z
dc.date.issued	2014
dc.identifier.citation	Konkov D. G. The comparison assessment of effectiveness of low-dose aspirin in women with gestational endotheliopathy for prevention of preeclampsia depending on beginning of treatment / D. G. Konkov // Austrian Journal of Technical and Natural Sciences. - 2014. - № 1. – Р. 46-50.	en
dc.identifier.issn	2310-5607
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/1094
dc.description.abstract	We are estimated the effect of low-dose aspirin (75 mg/day) depending on beginning (gestational age 11-14 vs. 16-20 weeks) in women with gestational endotheliopathy, on the incidence of preeclampsia and other perinatal complications. Our investigation showed statistically significant effect of low-dose aspirin initiated in 11-14 weeks in preventing the incidence of preeclampsia and IUGR in women with gestational endotheliopathy.	ru_RU
dc.language.iso	en	en
dc.publisher	Austrian Journal of Technical and Natural Sciences	en
dc.subject	gestational endotheliopathy	en
dc.subject	low-dose aspirin	en
dc.subject	preeclampsia	en
dc.subject	prevention	en
dc.title	The comparison assessment of effectiveness of low-dose aspirin in women with gestational endotheliopathy for prevention of preeclampsia depending on beginning of treatment	en
dc.type	Article	en